Public Company News
Trinasolar Releases Sustainability Report for 2023, Detailing its Commitment, Action and Achievements Towards a More Sustainable World
CHANGZHOU, China, June 3, 2024 /PRNewswire/ -- Trina Solar Co., Ltd. (688599.
SH), one of the world's leaders in smart PV and energy storage solutions,
recently released its2023 Sustainability Report
BRI Receives Analysts Buy Recommendation as MSMEs Financing Strategy Drives Growth
JAKARTA, Indonesia, June 3, 2024 /PRNewswire/ -- PT. Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)remains Indonesia's leading MSME (Micro, Small and Medium Enterprise) financier, with its credit portfolio growing toIDR 1,308.65 trillion by March 2024, up 10.89% year-on-year. Over 83% of this, o...
Primax's 40th Anniversary Virtual Expo: Unveiling AI Innovations for a Smarter Future
Aligned with COMPUTEX 2024, Primax Showcases 3 Senses in one Integration Solutions TAIPEI, June 3, 2024 /PRNewswire/ -- Primax Electronics Ltd., a leader in 3 senses in 1 (interface, visual, and audio) integrated solutions, announces its 40th Anniversary Virtual Expo startingJune 4th. Coinciding...
Ericsson announces conclusion of Monitorship
* Ericsson's Monitorship and Plea Agreement concluded on June 2 * Follows upon certification of Ericsson's anti-corruption compliance program by independent Monitor inMarch 2024 * Continuing to cooperate fully with DOJ and SEC investigations on historical conduct STOCKHOLM, June 3, 2024 /PRN...
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
TAOYUAN, June 3, 2024 /PRNewswire/ -- Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered inTaiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory located in suburban Chicago. SynChem will now operate under the new name SynChem-For...
Upcoming Acer Swift Series Laptops to Feature Models with New AMD Ryzen AI 300 Series Processors
TAIPEI, June 3, 2024 /PRNewswire/ -- Acer announced that its Swift series of thin-and-light laptops will feature models with the new AMD Ryzen™ AI 300 Series laptop processors, beginning in Q3 2024. Stacked with more CPU and GPU cores made available in this class of AMD-powered PCs, and equipped ...
Supermicro Liquid-Cooled AI SuperClusters Will Power Large-Scale AI Data Center in Japan
Working with Datasection, KDDI, and Sharp, Supermicro Will Deploy Rack Scale Plug-and-Play Liquid-Cooled AI Solutions with Advanced NVIDIA GPUs at a New AI Data Center -- AI Data Centers with Green Computing Can be Free with a Bonus SAN JOSE, Calif. and TAIPEI, June 3, 2024 /PRNewswire/ -- Compu...
Alphamab Oncology Presented Chinese Clinical Data of Anti-HER2 Bispecific ADC JSKN003 for the First Time at the 2024 ASCO Annual Meeting
* Results from the phase I part of JSKN003-102 was reported at this ASCO Annual Meeting. * JSKN003 exhibited a favorable tolerability and manageable safety profile in heavily pretreated patients with advanced/metastatic solid tumors and demonstrated encouraging antitumor activity during dose ...
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study Evaluating IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab as Neoadjuvant Treatment of Colon Cancer at 2024 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and ot...
Innovent Delivers Oral Presentations at the 2024 ASCO Annual Meeting on Clinical Data of First-in-Class anti-CLDN18.2/CD3 Bispecific Antibody (IBI389) for the Treatment of Advanced Pancreatic Cancer and Gastric Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of Stapokibart for the Treatment of Moderate-to-severe Atopic Dermatitis
CHENGDU, China, June 2, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe atopic dermatitis (AD) has been released by way of oral presentation...
Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging
MELBOURNE, Australia, June 3, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for its investigational radi...
Kerry Logistics Network Commended for Comprehensive Climate Disclosure at the HKQAA Hong Kong Green and Sustainability Contribution Awards 2024
HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) is delighted to be recognised once again by the Hong Kong Quality Assurance Agency ('HKQAA'), winning the Pioneering Award for Climate Disclosure Contribution for its not...
DB HiTek Advances Global Shutter and SPAD
* Expanding specialized image sensor business applied to machine vision, autonomous vehicles, robotics, and medical devices * Collaborating on product development with leading companies in the US, Japan , andChina by providing global leading-edge processes SEOUL, South Korea, June 3, 2024 /PRN...
Kerry Logistics Network Named Global Logistics Company of Excellence by Hong Kong Economic Journal Corporate Brand Awards of Excellence 2024
HONG KONG, June 3, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network', 'KLN'; Stock Code 0636.HK) has been named the Global Logistics Company of Excellence by the Hong Kong Economic Journal Corporate Brand Awards of Excellence (the 'Awards') 2024, for its excellent co...
Innovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib (JAB-21822) in combination with aSHP2 inhibitor (JAB-3312) in frontline non-small ...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
* EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and overall survival (OS) benefits of sugemalimab in combination with chemotherapy as a first-line treatment for non-small cell lung cancer (NSC...
Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
SAN FRANCISCO, U.S. and SUZHOU, China, June 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoi...
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1187 media titles]
2026-11-13 22:11The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1173 media titles]
2026-11-14 13:23Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1172 media titles]
2026-11-12 23:00Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1155 media titles]
2026-11-11 22:00Kraft Heinz Casts Spotlight on its NYSE Listing: NYSE Content Update
[Picked up by 1088 media titles]
2026-11-12 21:55